Tower Research Capital (TRC)’s Akcea Therapeutics, Inc. Common Stock AKCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-7,876
| Closed | -$143K | – | 5640 |
|
|
2020
Q3 | $143K | Buy |
7,876
+3,704
| +89% | +$67.3K | ﹤0.01% | 2864 |
|
|
2020
Q2 | $57K | Buy |
4,172
+4,072
| +4,072% | +$55.6K | ﹤0.01% | 2956 |
|
|
2020
Q1 | $1K | Sell |
100
-9,572
| -99% | -$95.7K | ﹤0.01% | 2926 |
|
|
2019
Q4 | $164K | Buy |
+9,672
| New | +$164K | 0.01% | 675 |
|
|
2019
Q2 | – | Sell |
-200
| Closed | -$6K | – | 4627 |
|
|
2019
Q1 | $6K | Buy |
200
+102
| +104% | +$3.06K | ﹤0.01% | 3011 |
|
|
2018
Q4 | $3K | Buy |
+98
| New | +$3K | ﹤0.01% | 3274 |
|
|
2018
Q3 | – | Sell |
-3,477
| Closed | -$82K | – | 4478 |
|
|
2018
Q2 | $82K | Buy |
3,477
+1,882
| +118% | +$44.4K | ﹤0.01% | 1563 |
|
|
2018
Q1 | $41K | Sell |
1,595
-2,278
| -59% | -$58.6K | ﹤0.01% | 1790 |
|
|
2017
Q4 | $67K | Sell |
3,873
-3,181
| -45% | -$55K | 0.01% | 1122 |
|
|
2017
Q3 | $195K | Buy |
+7,054
| New | +$195K | 0.02% | 791 |
|